# The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)

Study · id `cardio:ct-nct01665053` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01665053](<https://clinicaltrials.gov/study/NCT01665053>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01665053

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1684 participants.

## Technical summary

Registry record NCT01665053. Randomized; single masking; primary purpose treatment. Start 2012-11 (registry gives no type); primary completion 2014-09 (actual). Results posted on 2016-01-07.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 1684 participants (enrolled count; ClinicalTrials.gov record NCT01665053, source copy `cardio:ctgov-nct01665053-2019-01-30`, retrieved 2026-10-26)
- Start date: 2012-11 (registry gives no type) (ClinicalTrials.gov record NCT01665053, source copy `cardio:ctgov-nct01665053-2019-01-30`, retrieved 2026-10-26)
- Primary completion: 2014-09 (actual) (ClinicalTrials.gov record NCT01665053, source copy `cardio:ctgov-nct01665053-2019-01-30`, retrieved 2026-10-26)
- Completion: 2018-12-22 (actual) (ClinicalTrials.gov record NCT01665053, source copy `cardio:ctgov-nct01665053-2019-01-30`, retrieved 2026-10-26)
- Results first posted: 2016-01-07 (ClinicalTrials.gov record NCT01665053, source copy `cardio:ctgov-nct01665053-2019-01-30`, retrieved 2026-10-26)
- Countries: United States; Australia; Austria; Belgium; Canada; Denmark; Finland; France; Italy; Japan; Latvia; Netherlands; New Zealand; Poland; Singapore; Spain (ClinicalTrials.gov record NCT01665053, source copy `cardio:ctgov-nct01665053-2019-01-30`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01665053-2019-01-30`, retrieved 2026-10-26)

## The registry's words

- Brief title: The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)
- Condition: Coronary Artery Disease
- Intervention (Device): PROMUS Element Plus
- Intervention (Device): SYNERGY
- Lead sponsor: Boston Scientific Corporation
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Boston Scientific (`cardio:boston-scientific`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Efficacy and safety of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent: the EVOLVE II Randomized Trial (`cardio:pubmed-25855680`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Clinical Outcomes Following Implantation of Thin-Strut, Bioabsorbable Polymer-Coated, Everolimus-Eluting SYNERGY Stents (`cardio:pubmed-31451014`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: a64b1b2f9cdef952d282f0557dbccf47dc051da5a6aee6171e43e7823084fcc1
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
